Literature DB >> 8647296

Molecular cloning of a levocabastine-sensitive neurotensin binding site.

P Chalon1, N Vita, M Kaghad, M Guillemot, J Bonnin, B Delpech, G Le Fur, P Ferrara, D Caput.   

Abstract

A search for sequences homologous to the neurotensin receptor cDNA in a rat hypothalamic library has identified a novel neurotensin receptor (NTR-2). The 1539 bp cDNA encodes a 416 amino acid protein and shows highest homology to the previously cloned neurotensin receptor (NTR-1) (64% homology and 43% identity). Binding and pharmacological studies demonstrate that NTR-2 expressed in COS cells recognizes neurotensin (NT) with high affinity as well as several other agonists and antagonists. However, a fundamental difference was found; unlike NTR-1, NTR-2 recognizes, with high affinity, levocabastine, a histamine H1 receptor antagonist previously shown to compete with NT for low-affinity binding sites in brain.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8647296     DOI: 10.1016/0014-5793(96)00397-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  52 in total

1.  In vitro functional evidence of different neurotensin-receptors modulating the motor response of human colonic muscle strips.

Authors:  T Croci; G Aureggi; F Guagnini; L Manara; D Gully; G L Fur; J P Maffrand; S Mukenge; G Ferla; P Ferrara; P Chalon; N Vita
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

2.  Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression.

Authors:  B M Tyler; K Jansen; D J McCormick; C L Douglas; M Boules; J A Stewart; L Zhao; B Lacy; B Cusack; A Fauq; E Richelson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

3.  Modulation of the interaction between neurotensin receptor NTS1 and Gq protein by lipid.

Authors:  Sayaka Inagaki; Rodolfo Ghirlando; Jim F White; Jelena Gvozdenovic-Jeremic; John K Northup; Reinhard Grisshammer
Journal:  J Mol Biol       Date:  2012-01-27       Impact factor: 5.469

Review 4.  Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?

Authors:  Guy Griebel; Florian Holsboer
Journal:  Nat Rev Drug Discov       Date:  2012-05-18       Impact factor: 84.694

5.  Increased ethanol consumption and preference in mice lacking neurotensin receptor type 2.

Authors:  Moonnoh R Lee; David J Hinton; Sencan S Unal; Elliott Richelson; Doo-Sup Choi
Journal:  Alcohol Clin Exp Res       Date:  2010-10-06       Impact factor: 3.455

Review 6.  The role of neurotensin in central nervous system pathophysiology: what is the evidence?

Authors:  Fannie St-Gelais; Claudia Jomphe; Louis-Eric Trudeau
Journal:  J Psychiatry Neurosci       Date:  2006-07       Impact factor: 6.186

7.  Diverse actions of the modulatory peptide neurotensin on central synaptic transmission.

Authors:  Christopher W Tschumi; Michael J Beckstead
Journal:  Eur J Neurosci       Date:  2018-02-28       Impact factor: 3.386

8.  Correlative ultrastructural distribution of neurotensin receptor proteins and binding sites in the rat substantia nigra.

Authors:  H Boudin; D Pélaprat; W Rostène; V M Pickel; A Beaudet
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

9.  Identification of the receptor subtype involved in the analgesic effect of neurotensin.

Authors:  I Dubuc; P Sarret; C Labbé-Jullié; J M Botto; E Honoré; E Bourdel; J Martinez; J Costentin; J P Vincent; P Kitabgi; J Mazella
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

10.  Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism.

Authors:  Arti B Patel; Irene Tsilioni; Susan E Leeman; Theoharis C Theoharides
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.